Massive rearrangements of cellular MicroRNA signatures are key drivers of hepatocyte dedifferentiation

Hepatology

Volumn 64, Issue 5, 2016, Pages 1743-1756

  Lauschke, Volker M ^a   Vorrink, Sabine U ^a   Moro, Sabrina M L ^a   Rezayee, Fatemah ^a   Nordling, Åsa ^a   Hendriks, Delilah F G ^a   Bell, Catherine C ^a   Sison Young, Rowena ^b   Park, B Kevin ^b   Goldring, Christopher E ^b   Ellis, Ewa ^c   Johansson, Inger ^a   Mkrtchian, Souren ^a   Andersson, Tommy B ^a,d   Ingelman Sundberg, Magnus ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIFLAVINE; LONG UNTRANSLATED RNA; MICRORNA; POLYLYSINE; PROTEOME; RIBOSOME PROTEIN; SMALL NUCLEOLAR RNA; TRANSCRIPTOME;

ADULT; AGED; ARTICLE; CELL DEDIFFERENTIATION; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; LIVER CELL; LIVER REGENERATION; MALE; PRIORITY JOURNAL; CELL CULTURE; GENETICS; MIDDLE AGED; PHYSIOLOGY;

ADULT; AGED; CELL DEDIFFERENTIATION; CELLS, CULTURED; FEMALE; HEPATOCYTES; HUMANS; MALE; MICRORNAS; MIDDLE AGED; TRANSCRIPTOME;

EID: 84990068703     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.28780     Document Type: Article

References (49)

1. Michalopoulos GK. Liver regeneration. J Cell Physiol 2007;213:286–300.
2. Fausto N, Campbell JS, Riehle KJ. Liver regeneration. Hepatology 2006;43(2 Suppl 1):S45–S53.
3. Yovchev MI, Grozdanov PN, Zhou H, Racherla H, Guha C, Dabeva MD, et al. Identification of adult hepatic progenitor cells capable of repopulating injured rat liver. Hepatology 2007;47:636–647.
4. Kordes C, Häussinger D. Hepatic stem cell niches. J Clin Invest 2013;123:1874–1880.
5. Evarts RP, Nagy P, Marsden E, Thorgeirsson SS. A precursor-product relationship exists between oval cells and hepatocytes in rat liver. Carcinogenesis 1987;8:1737–1740.
6. Schaub JR, Malato Y, Gormond C, Willenbring H. Evidence against a stem cell origin of new hepatocytes in a common mouse model of chronic liver injury. Cell Rep 2014;8:933–939.
7. Yanger K, Knigin D, Zong Y, Maggs L, Gu G, Akiyama H, et al. Adult hepatocytes are generated by self-duplication rather than stem cell differentiation. Cell Stem Cell 2014;15:340–349.
8. Yanger K, Zong Y, Maggs LR, Shapira SN, Maddipati R, Aiello NM, et al. Robust cellular reprogramming occurs spontaneously during liver regeneration. Genes Dev 2013;27:719–724.
9. Tarlow BD, Pelz C, Naugler WE, Wakefield L, Wilson EM, Finegold MJ, Grompe M, et al. Bipotential adult liver progenitors are derived from chronically injured mature hepatocytes. Stem Cell 2014;15:605–618.
10. Chen Y, Wong PP, Sjeklocha L, Steer CJ, Sahin MB. Mature hepatocytes exhibit unexpected plasticity by direct dedifferentiation into liver progenitor cells in culture. Hepatology 2012;55:563–574.
11. Rowe C, Gerrard DT, Jenkins R, Berry A, Durkin K, Sundstrom L, et al. Proteome-wide analyses of human hepatocytes during differentiation and dedifferentiation. Hepatology 2013;58:799–809.
12. Baker TK, Carfagna MA, Gao H, Dow ER, Li Q, Searfoss GH, Ryan TP, et al. Temporal gene expression analysis of monolayer cultured rat hepatocytes. Chem Res Toxicol 2001;14:1218–1231.
13. Cech TR, Steitz JA. The noncoding RNA revolution—trashing old rules to forge new ones. Cell 2014;157:77–94.
14. Wilczynska A, Bushell M. The complexity of miRNA-mediated repression. Cell Death Differ 2015;22:22–33.
15. Gamazon ER, Innocenti F, Wei R, Wang L, Zhang M, Mirkov S, et al. A genome-wide integrative study of microRNAs in human liver. BMC Genomics 2013;14:395.
16. Kim N, Kim H, Jung I, Kim Y, Kim D, Han YM, et al. Expression profiles of miRNAs in human embryonic stem cells during hepatocyte differentiation. Hepatol Res 2011;41:170–183.
17. Clouet d'Orval B, Bortolin ML, Gaspin C, Bachellerie JP. Box C/D RNA guides for the ribose methylation of archaeal tRNAs. The tRNATrp intron guides the formation of two ribose-methylated nucleosides in the mature tRNATrp. Nucleic Acids Res 2011;29:4518–4529.
18. Decatur WA, Fournier MJ. rRNA modifications and ribosome function. Trends Biochem Sci 2002;27:344–351.
19. Taft RJ, Glazov EA, Lassmann T, Hayashizaki Y, Carninci P, Mattick JS, et al. Small RNAs derived from snoRNAs. RNA 2009;15:1233–1240.
20. Kishore S, Kanna A, Zhang Z, Hui J, Balwierz PJ, Stefan M, et al. The snoRNA MBII-52 (SNORD 115) is processed into smaller RNAs and regulates alternative splicing. Hum Mol Genet 2010;19:1153–1164.
21. Ender C, Krek A, Friedländer MR, Beitzinger M, Weinmann L, Chen W, et al. A Human snoRNA with microRNA-like functions. Mol Cell 2008;32:519–528.
22. Sharma E, Sterne-Weiler T, O'Hanlon D, Blencowe BJ. Global mapping of human RNA-RNA interactions. Mol Cell 2016;62:618–626.
23. Kung JT, Colognori D, Lee JT. Long noncoding RNAs: past, present, and future. Genetics 2013;193:651–669.
24. Strom SC, Pisarov LA, Dorko K, Thompson MT, Schuetz JD, Schuetz EG, et al. Use of human hepatocytes to study P450 gene induction. Methods Enzymol 1996;272:388–401.
25. Wang J, Duncan D, Shi Z, Zhang B. WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013. Nucleic Acids Res 2013;41(Web Server issue):W77–W83.
26. Yang J, Liao M, Shou M, Jamei M, Rowland Yeo K, Tucker GT, Rostami-Hodjegan A, et al. Cytochrome p450 turnover: regulation of synthesis and degradation, methods for determining rates, and implications for the prediction of drug interactions. Curr Drug Metab 2008;9:384–394.
27. Andersson R, Gebhard C, Miguel-Escalada I, Hoof I, Bornholdt J, Boyd M, et al. An atlas of active enhancers across human cell types and tissues. Nature 2014;507:455–461.
28. Watashi K, Yeung ML, Starost MF, Hosmane RS, Jeang KT. Identification of small molecules that suppress microRNA function and reverse tumorigenesis. J Biol Chem 2010;285:24707–24716.
29. Trajkovski M, Hausser J, Soutschek J, Bhat B, Akin A, Zavolan M, et al. MicroRNAs 103 and 107 regulate insulin sensitivity. Nature 2011;474:649–653.
30. Liu M, Wu H, Liu T, Li Y, Wang F, Wan H, et al. Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma. Cell Res 2009;19:828–837.
31. John K, Hadem J, Krech T, Wahl K, Manns MP, Dooley S, et al. MicroRNAs play a role in spontaneous recovery from acute liver failure. Hepatology 2014;60:1346–1355.
32. Fornari F, Gramantieri L, Ferracin M, Veronese A, Sabbioni S, Calin GA, et al. miR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. Oncogene 2008;27:5651–5661.
33. Cirera-Salinas D, Pauta M, Allen RM, Salerno AG, Ramirez CM, Chamorro-Jorganes A, et al. Mir-33 regulates cell proliferation and cell cycle progression. Cell Cycle 2012;11:922–933.
34. Zhang SY, Surapureddi S, Coulter S, Ferguson SS, Goldstein JA. Human CYP2C8 is post-transcriptionally regulated by microRNAs 103 and 107 in human liver. Mol Pharmacol 2012;82:529–540.
35. Azimifar SB, Nagaraj N, Cox J, Mann M. Cell-type-resolved quantitative proteomics of murine liver. Cell Metab 2014;20:1076–1087.
36. Xiao L, Grove A. Coordination of ribosomal protein and ribosomal RNA gene expression in response to TOR signaling. Curr Genomics 2009;10:198–205.
37. Kimball SR. Eukaryotic initiation factor eIF2. Int J Biochem Cell Biol 1999;31:25–29.
38. Diederichs S, Haber DA. Dual role for argonautes in microRNA processing and posttranscriptional regulation of microRNA expression. Cell 2007;131:1097–1108.
39. Gantier MP, McCoy CE, Rusinova I, Saulep D, Wang D, Xu D, et al. Analysis of microRNA turnover in mammalian cells following Dicer1 ablation. Nucleic Acids Res 2011;39:5692–5703.
40. Olejniczak SH, La Rocca G, Gruber JJ, Thompson CB. Long-lived microRNA-Argonaute complexes in quiescent cells can be activated to regulate mitogenic responses. Proc Natl Acad Sci U S A 2013;110:157–162.
41. Runge DM, Runge D, Dorko K, Pisarov LA, Leckel K, Kostrubsky VE, et al. Epidermal growth factor- and hepatocyte growth factor-receptor activity in serum-free cultures of human hepatocytes. J Hepatol 1999;30:265–274.
42. Yu D, Green B, Marrone A, Guo Y, Kadlubar S, Lin D, et al. Suppression of CYP2C9 by microRNA hsa-miR-128-3p in human liver cells and association with hepatocellular carcinoma. Sci Rep 2015;5:8534–8539.
43. Wei Z, Jiang S, Zhang Y, Wang X, Peng X, Meng C, et al. The effect of microRNAs in the regulation of human CYP3A4: a systematic study using a mathematical model. Sci Rep 2014;4:1–7.
44. Li Z, Rana TM. Therapeutic targeting of microRNAs: current status and future challenges. Nat Genet 2014;13:622–638.
45. Schug J, McKenna LB, Walton G, Hand N, Mukherjee S, Essuman K, et al. Dynamic recruitment of microRNAs to their mRNA targets in the regenerating liver. BMC Genomics 2013;14:264.
46. Elaut G, Henkens T, Papeleu P, Snykers S, Vinken M, Vanhaecke T, Rogiers V, et al. Molecular mechanisms underlying the dedifferentiation process of isolated hepatocytes and their cultures. Curr Drug Metab 2006;7:629–660.
47. Godoy P, Hengstler JG, Ilkavets I, Meyer C, Bachmann A, Müller A, et al. Extracellular matrix modulates sensitivity of hepatocytes to fibroblastoid dedifferentiation and transforming growth factor β-induced apoptosis. Hepatology 2009;49:2031–2043.
48. Bell CC, Hendriks DF, Moro SM, Ellis E, Walsh J, Renblom A, et al. Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease. Sci Rep 2016;6:25187.
49. Bronevetsky Y, Villarino AV, Eisley CJ, Barbeau R, Barczak AJ, Heinz GA, et al. T cell activation induces proteasomal degradation of Argonaute and rapid remodeling of the microRNA repertoire. J Exp Med 2013;210:417–432.